Bortezomib-Dexamethasone-Doxorubicin-Study
NCT00401804
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Renal Insuficiency
Interventions
DRUG:
Dexamethasone, Bortezomib, Doxorubicin
Sponsor
Austrian Forum Against Cancer